The most appropriate Group for Breast: Invasive Carcinoma…Histologic, Ductal
Cancer: Breast Specific RDPV3 GROUP 16: 0.02, 0.46, 5.12, 27.5, 85, 95.75, 150, 434.71, 682.45, 753.07
Use a RHM over the breast area so that the frequencies are localized to the treatment areas.
If there are skin sensitivities then wear a thin tshirt between the mat and the skin surface.
Best results are overnight treatments using the mat wrap. If one needs to use the bathroom, simply unplug the White RCA cable from the RDPV3 and replug the cable when returning to bed. No requirement to “pause” or adjust buttons.
Over the past 12 months, a range of alternative treatment approaches has gained increased attention within patient communities and some areas of research. Among these, anti-parasitic therapies have been discussed as a potential strategy for targeting certain types of cancer which include ‘Breast: Invasive Carcinoma’
Preliminary laboratory findings and anecdotal reports have contributed to growing interest in this area, suggesting that some anti-parasitic agents disrupt tumor growth.
Antiparasitic drugs have been studied as potential cancer treatments:
Most of the evidence supporting their use in cancer comes from laboratory and early-stage research. Researchers are investigating certain antiparasitic drugs because they appear to affect biological pathways that cancer cells depend on for growth and survival.
One example is Ivermectin, originally used to treat parasitic infections like river blindness. In laboratory studies, it has been shown to inhibit cancer cell growth pathways such as WNT/β-catenin signaling, block tumor cell proliferation, induce apoptosis (programmed cancer cell death), interfere with nuclear transport proteins that cancer cells rely on, and reduce cancer stem cell activity.
Another drug being studied is Mebendazole, which is used to treat intestinal worm infections. It disrupts microtubules—structures essential for cell division—in a way that is similar to some chemotherapy drugs. By interfering with microtubules, it blocks the division of rapidly growing cancer cells. It has also shown potential anti-angiogenic effects, meaning it may inhibit the formation of new blood vessels that tumors need to grow.
Fenbendazole, a veterinary dewormer, has gained attention online due to it also being used as a cancer treatment. It is thought to interfere with microtubules and possibly disrupt cancer cell metabolism.
Niclosamide, used to treat tapeworm infections, is also being researched for potential anti-cancer effects. Laboratory studies suggest it inhibits important cancer signaling pathways such as Wnt, STAT3, and NF-κB, disrupt mitochondrial function in cancer cells, and affect tumor metabolism.
Scientists are interested in these drugs because they are already approved for parasitic infections, their safety profiles are relatively well known, they are inexpensive and widely available, and drug repurposing can be faster and less costly than developing entirely new medications.
